Sugar-Sweetened Beverages May Raise Risk of  Hepatic Cancer Subtypes - Scorecard - MDSpire

Sugar-Sweetened Beverages May Raise Risk of  Hepatic Cancer Subtypes

In a pooled analysis of more than 1.5 million patients, sugar-sweetened beverages were associated with higher risks of HCC and ICC, while artificially-sweetened beverages showed no independent association with hepatic cancer.

  • By

  • Andrea Surnit

  • June 10, 2026

  • 3 min

Share

Clinical Scorecard: Sugar-Sweetened Beverages May Raise Risk of Hepatic Cancer Subtypes

At a Glance

CategoryDetail
Condition
Key MechanismsHigher consumption of sugar-sweetened beverages is associated with increased risk of HCC and ICC.
Target Population
Care Setting

Key Highlights

  • Pooled analysis of over 1.5 million patients from 11 studies.
  • Each additional daily sugar-sweetened beverage linked to 10% higher likelihood of HCC and 15% higher likelihood of ICC.
  • Artificially-sweetened beverages showed no association with hepatic cancer risk.
  • Limitations include self-reported beverage consumption and incomplete data on liver disease.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider monitoring beverage intake based on study findings.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Adults without a history of cancer.

        No specific treatment insights provided; focus on beverage consumption.

        Clinical Best Practices

        • Assess dietary habits in relation to cancer risk factors.

        Related Resources & Content

        Original Source(s)

        Sugar-Sweetened Beverages May Raise Risk of  Hepatic Cancer Subtypes

        • by Andrea Surnit

        • June 10, 2026

        Related Content

        Secular trends in HbA1c levels among children and adolescents with type 1 diabetes

        HNF1B-MODY (MODY-5): a rare form of diabetes with multisystemic features–two case reports

        Study Reassures on Safety of Early NSAID Use

        A large cohort found no adjusted link to major congenital malformations, but questions remain for miscarriage, later pregnancy, and other outcomes.